Research Instruments GmbH Awarded Contract for Superconducting Accelerating Modules from Turkey
BERGISCH GLADBACH, Germany – September 05, 2012 - RI Research Instruments GmbH (RI), a majority-owned subsidiary of Bruker Energy & Supercon Technologies, Inc. (BEST), today announced the award of a major contract by the Turkish Accelerator Center (TAC). Valued at approximately $4.8 million USD. The contract covers two turnkey superconducting accelerating modules based on a design developed by Helmholtz-Zentrum Dresden Rossendorf, including four European XFEL type accelerating cavities.
A primary goal of the TAC project is to establish the first accelerator based infrared free electron laser (FEL) light source facility in Turkey in order to improve access for Turkish scientists to advanced scientific research infrastructure at the Turkish Accelerator and Radiation Laboratory at Ankara (TARLA).
Dr. Michael Peiniger, Managing Director of RI Research Instruments GmbH, explained: “These superconducting accelerating modules will be based on our unique advanced technology. We expect that their delivery will support the start-up of the TAC facility in 2014 and will be the basis for a long-term partnership between RI and the Turkish accelerator community.”
About RI Research Instruments and Bruker Energy & Supercon Technologies, Inc.:
RI Research Instruments GmbH is a world leader in the development and manufacturing of normal and superconducting rf cavities and systems, linear accelerators, as well as special products for physics and energy research, scientific, medical and industrial applications. RI products also include high-performance electron and ion sources, particle beamlines and diagnostics, research reactor subunits, as well as vacuum and cryogenic systems. BEST has operations in the US, the UK and in Germany, and is a wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR).
For more information on RI or BEST, please visit: Research Instruments or Bruker EST
SOURCE: Bruker Energy & Supercon Technologies, Inc.
For further Information:
Managing Director, RI
Tel. +49 (0)2204 7062 3513